323 related articles for article (PubMed ID: 25691459)
1. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
Yao L; Han C; Song K; Zhang J; Lim K; Wu T
Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
3. miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
Lu L; Byrnes K; Han C; Wang Y; Wu T
Mol Cancer Res; 2014 Jun; 12(6):890-900. PubMed ID: 24699315
[TBL] [Abstract][Full Text] [Related]
4. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
Lu D; Han C; Wu T
J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.
Zhang J; Han C; Wu T
Gastroenterology; 2012 Jul; 143(1):246-56.e8. PubMed ID: 22484120
[TBL] [Abstract][Full Text] [Related]
6. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
7. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
Wang P; Lv L
Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
[TBL] [Abstract][Full Text] [Related]
8. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
9. The ω-3 polyunsaturated fatty acids prevented colitis-associated carcinogenesis through blocking dissociation of β-catenin complex, inhibiting COX-2 through repressing NF-κB, and inducing 15-prostaglandin dehydrogenase.
Han YM; Jeong M; Park JM; Kim MY; Go EJ; Cha JY; Kim KJ; Hahm KB
Oncotarget; 2016 Sep; 7(39):63583-63595. PubMed ID: 27566583
[TBL] [Abstract][Full Text] [Related]
10. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
Shu L; Li X; Liu Z; Li K; Shi A; Tang Y; Zhao L; Huang L; Zhang Z; Zhang D; Huang S; Lian S; Sheng G; Yan Z; Zhang Z; Xu Y
Hepatology; 2024 Feb; 79(2):307-322. PubMed ID: 37140231
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
12. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
14. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Silencing of 15-Hydroxyprostaglandin Dehydrogenase by Histone Methyltransferase EHMT2/G9a in Cholangiocarcinoma.
Zhang J; Chen W; Ma W; Song K; Lee S; Han C; Wu T
Mol Cancer Res; 2022 Mar; 20(3):350-360. PubMed ID: 34880125
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids suppress metastatic features of human cholangiocarcinoma cells by suppressing twist.
Lin CR; Chu TM; Luo A; Huang SJ; Chou HY; Lu MW; Wu JL
J Nutr Biochem; 2019 Dec; 74():108245. PubMed ID: 31678746
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
18. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
19. Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18.
Han YM; Park JM; Cha JY; Jeong M; Go EJ; Hahm KB
Int J Cancer; 2016 May; 138(9):2247-56. PubMed ID: 26650508
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
Kim HR; Lee HN; Lim K; Surh YJ; Na HK
Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
